Company Search:
Advanced Search
Sponsored Links
AddLife AB Company Snapshot
AddLife AB operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares AddLife AB with three other miscellaneous service companies in Europe: Basilea Pharmaceutica Limited of SWITZERLAND (2019 sales of 114.79 million Swiss Francs [US$117.49 million] ), GW Pharmaceuticals PLC of UNITED KINGDOM (£243.39 million [US$289.41 million] of which 100% was Novel Therapeutics), and Clinigen Group PLC which is also based in UNITED KINGDOM (£456.90 million [US$543.28 million] of which 45% was Unlicensed Medicines).

Sales Analysis. AddLife AB reported sales of SEK 3.48 billion (US$343.90 million) for the year ending December of 2019. This represents an increase of 40.2% versus 2018, when the company's sales were SEK 2.48 billion. Sales at AddLife AB have increased during each of the previous five years (and since 2014, sales have increased a total of 254%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
AddLife AB
  Stock Performance Chart for AddLife AB
  Stock Data: Recent Stock Performance:
  Current Price (3/27/2020): 276.00
(Figures in Swedish Kronor)
1 Week 9.1%   13 Weeks -13.8%  
4 Weeks -5.5%   52 Weeks 17.4%  
AddLife AB Key Data:
  Ticker: ALIF B Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 3,479,000,000
(Year Ending Jan 2020).
Employees: 873
  Currency: Swedish Kronor Market Cap: 7,744,373,148
  Fiscal Yr Ends: December Shares Outstanding: 28,059,323
  Share Type: AKTIE Closely Held Shares: 4,762,503
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.